Saba Capital Management, L.P.
Position in ASBP — Aspire Biopharma Holdings, Inc.
CIK 1510281
NEW YORK, NY
Position in ASBP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
983,603
0.0% QoQ
Ownership
70.1%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saba Capital Management, L.P. holds $533,158 across 8 Biotechnology names. ASBP ranks #3 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
39,640 | $533,158 | |
| 2 | OSRH |
OSR Health, Inc.
|
250,000 | $0 | |
| 3 | ASBP |
Aspire Biopharma Holdings, Inc.
This page
|
983,603 | $0 | |
| 4 | OABIW |
OmniAb, Inc.
|
18,000 | $0 | |
| 5 | PBM |
Psyence Biomedical Ltd.
|
297,847 | $0 | |
| 6 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
199,839 | $0 | |
| 7 | LIMN |
Liminatus Pharma, Inc.
|
233,761 | $0 | |
| 8 | CDT |
CDT Equity Inc.
|
765,000 | $0 |
All Filings in ASBP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 ASBPW | — | 983,603 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 ASBPW | — | 983,603 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 ASBPW | — | 983,603 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 ASBPW | — | 983,603 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 ASBPW | — | 983,603 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 ASBPW | — | 983,603 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||